TransMedics Group Inc (TMDX)

Exchange
NASDAQ
Symbol
TMDX
Sector
Life Sciences
Industry
Electromedical & Electrotherapeutic Apparatus
Description
TransMedics Group, Inc., a commercial-stage medical technology company, is dedicated to transforming organ transplant therapy for patients with end-stage organ failure in the United States and internationally. The company is headquartered in Andover, Massachusetts.
Country
USA

Stock price

At close: February 5, 2026

  • Open
    127.28
  • High
    132.19
  • Low
    127.00
  • Close
    129.60
  • Volume
    806,845

Financial ratios

Dec 31, 2024